208 related articles for article (PubMed ID: 24686170)
21. MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
Biswas M; Chatterjee SS; Boila LD; Chakraborty S; Banerjee D; Sengupta A
FASEB J; 2019 Apr; 33(4):5268-5286. PubMed ID: 30668141
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
Ichihara E; Kaneda K; Saito Y; Yamakawa N; Morishita K
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):239-45. PubMed ID: 22033412
[TBL] [Abstract][Full Text] [Related]
23. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.
Zhang H; Alberich-Jorda M; Amabile G; Yang H; Staber PB; Di Ruscio A; Welner RS; Ebralidze A; Zhang J; Levantini E; Lefebvre V; Valk PJ; Delwel R; Hoogenkamp M; Nerlov C; Cammenga J; Saez B; Scadden DT; Bonifer C; Ye M; Tenen DG
Cancer Cell; 2013 Nov; 24(5):575-88. PubMed ID: 24183681
[TBL] [Abstract][Full Text] [Related]
24. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
25. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.
Cloos PA; Christensen J; Agger K; Maiolica A; Rappsilber J; Antal T; Hansen KH; Helin K
Nature; 2006 Jul; 442(7100):307-11. PubMed ID: 16732293
[TBL] [Abstract][Full Text] [Related]
26. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
Chen M; Zhu N; Liu X; Laurent B; Tang Z; Eng R; Shi Y; Armstrong SA; Roeder RG
Genes Dev; 2015 Oct; 29(20):2123-39. PubMed ID: 26494788
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
[TBL] [Abstract][Full Text] [Related]
28. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.
Müller-Tidow C; Klein HU; Hascher A; Isken F; Tickenbrock L; Thoennissen N; Agrawal-Singh S; Tschanter P; Disselhoff C; Wang Y; Becker A; Thiede C; Ehninger G; zur Stadt U; Koschmieder S; Seidl M; Müller FU; Schmitz W; Schlenke P; McClelland M; Berdel WE; Dugas M; Serve H;
Blood; 2010 Nov; 116(18):3564-71. PubMed ID: 20498303
[TBL] [Abstract][Full Text] [Related]
29. Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells.
Eshel R; Ben-Zaken O; Vainas O; Nadir Y; Minucci S; Polliack A; Naparstek E; Vlodavsky I; Katz BZ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1115-22. PubMed ID: 16112651
[TBL] [Abstract][Full Text] [Related]
30. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
31. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
32. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
[TBL] [Abstract][Full Text] [Related]
33. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
34. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
[TBL] [Abstract][Full Text] [Related]
35. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia.
Tian C; Yu Y; Jia Y; Zhu L; Zhang Y
Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281
[TBL] [Abstract][Full Text] [Related]
36. CTCF boundary remodels chromatin domain and drives aberrant
Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
[No Abstract] [Full Text] [Related]
37. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
38. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
39. Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.
Cheung N; Fung TK; Zeisig BB; Holmes K; Rane JK; Mowen KA; Finn MG; Lenhard B; Chan LC; So CW
Cancer Cell; 2016 Jan; 29(1):32-48. PubMed ID: 26766589
[TBL] [Abstract][Full Text] [Related]
40. Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells.
Agger K; Miyagi S; Pedersen MT; Kooistra SM; Johansen JV; Helin K
Genes Dev; 2016 Jun; 30(11):1278-88. PubMed ID: 27257215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
